Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

Phase 1, open label, multicenter, dose escalation study of YTB323 in adult patients with CLL/SLL and DLBCL

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03960840
Protocol Number
NSH1325
Phase
I
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Lymphoid Leukemia
Non-Hodgkin's Lymphoma
Sponsor Protocol
CYTB323A12101
Principal Investigator
Scott Solomon
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us